20VC: Inside Accel's $4BN Growth Investing Machine | Cursor is Dead is Total BS: Here is Why | What Missing Rippling and ElevenLabs Taught Us | Are $2BN-$10BN IPOs Dead | Why Now is a Great Time to be Thoma Bravo with Miles Clements

What It Covers

Accel growth partner Miles Clements discusses Cursor's $2B ARR trajectory, why the "Cursor is dead" narrative misreads agent adoption data, lessons from missing Rippling and ElevenLabs, the framework for evaluating AI company durability, and why the $2B–$10B IPO range has become structurally difficult for companies seeking public market success.

Key Questions Answered

• •AI Valuation Framework: Evaluate AI companies on two axes: time-to-value and durability-of-value. Coding tools like Cursor score high on both — users become productive within hours, and value compounds as teams scale agent usage. Legal and accounting AI scores low on time-to-value but high on durability. Vibe-coding apps score high on speed but collapse on durability. Map any AI investment against both dimensions before committing capital.
• •Cursor Agent Adoption Data: The "Cursor is dead" narrative ignores published metrics: 90% of Cursor users are daily active agent users, agent usage grew 15x last year, and the cloud agent product — live only since October — now accounts for 35% of all merged pull requests. When evaluating whether a product is losing relevance, prioritize usage intensity and engagement depth over anecdotal developer commentary on social media.
• •Missing Rippling — What Went Wrong: Accel passed on Rippling partly due to founder reputation concerns and rigid ownership thresholds at high valuations. The core miss was underweighting what Clements calls "marginal ease of ARR accumulation" — Parker Conrad's ability to build compounding revenue levers like laptop provisioning and IT leasing that seem unattractive standalone but become powerful as bundled revenue lines inside a platform business.
• •Revenue Predictions as Assumption Encoders: Cursor was projected to reach $300M ARR by year-end; it reached billions. Clements frames revenue forecasts not as targets to hold founders accountable to quarterly, but as encoded business assumptions — if pricing, product, and segment penetration work, this is the rough output. Missing by 10% in either direction is irrelevant for private investors; the inputs matter far more than the output number.
• •The $2B–$10B IPO Dead Zone: Companies going public in the $2B–$10B valuation range consistently struggle to break through to the next tier in public markets. The practical threshold for a viable IPO is clear line-of-sight to sustaining above $5B market cap. Below that, public market dynamics — including activist reports and macro sensitivity — create structural headwinds. Companies without Stripe or Databricks-scale optionality should reconsider timing and explore private liquidity alternatives first.
• •Investing as Art and Science: The science of investing is correctly valuing a company; the art is knowing when to break the rules. Accel lost ServiceTitan by rigidly capping vertical SaaS multiples at 6–10x forward revenue, missing a $9B outcome. Rules exist as defaults, not absolutes. When a founder can articulate a platform-scale outcome with clear market depth — even in vertical SaaS — the framework should bend to the evidence, not override it.